"Corporate Value and Return Enhancement" Action Plan 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
"Corporate Value and Return Enhancement" Action Plan 2024
Filed with SSE ·
"Corporate Value and Return Enhancement" Action Plan 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Chemclin Diagnostics Co., Ltd. on 6ix
Earlier from Chemclin Diagnostics
- Announcement on Progress in Litigation
- Announcement on Implementation of Dividend Distribution for 2023
- Announcement on Resolutions of 2023 Annual General Meeting
- Announcement on Plan of Shareholding Reduction by Shareholders with Over 5% Shares
- Announcement on Attending Pharmaceutical Special Session of 2023 Annual Collective Performance Meeting of STAR Market and 2024 1st Quarter Performance Meeting
Later from Chemclin Diagnostics
- Announcement on Progress in Repurchasing Shares through Auction
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 5%
- Announcement on Resolution of the 10th Meeting of the 2nd Board of Supervisors
- Announcement on Participation in the 2024 Semi-annual Special Collective Performance Briefing for Medical Devices and Medical Equipment in STAR Market
- Announcement on the Expiration of Share Reduction Plan for Shareholders Over 5% Shareholding and Result of Shareholding Reduction
Follow Chemclin Diagnostics into a list and get an email when it puts out news.
Follow Chemclin Diagnostics